The neurohormonal system activation occurs early, preceding the appearance of symptoms. In HF, the impaired systolic function leads to a decrease in cardiac output. These changes in cardiac output, including decreased blood pressure, pulse pressure, and effective circulating arterial volume, are sensed by multiple peripheral baroreceptors in the aorta and carotid sinus, cardiopulmonary mechanoreceptors, chemoreceptors, and ergoreceptors. When there is diminished activation of these sensory receptors, they activate compensatory mechanisms to maintain cardiovascular homeostasis. The SNS is activated early, followed by the RAAS, and these maintain cardiac output through increased retention of sodium and water, peripheral arterial vasoconstriction, and increased myocardial contractility. Additional compensatory mechanisms include the release of inflammatory mediators, which play a role in cardiac repair and remodeling. In HF, counterregulatory systems that typically counteract SNS and RAAS activation also undergo significant changes, including reduced parasympathetic tone and increased resistance to natriuretic peptides. Collectively, these processes contribute to the broader concept of neurohormonal activation. In the short term, these mechanisms restore the cardiac output and homeostasis; nonetheless, sustained and unopposed expression of neurohormonal activation has deleterious effects on the heart and circulatory system, and is one of the most important mechanisms underlying the progression of HF and increased mortality in these patients. Understanding these mechanisms is crucial, as therapeutic interventions targeting neurohormonal systems have transformed HF management and form the cornerstone of modern pharmacotherapy for this condition.